期刊文献+

荧光原位杂交技术在膀胱癌诊断中的应用价值 被引量:7

Predictive value of fluorescence in situ hybridization in patients with bladder cancer
暂未订购
导出
摘要 目的探讨荧光原位杂交技术(FISH)在膀胱癌诊断中的价值,并与常规的尿脱落细胞学对比。方法收集100例疑似尿路移行上皮细胞肿瘤的血尿患者在行膀胱镜检查之前的尿液标本,分别做尿细胞学检测和荧光原位杂交分析。20例正常人尿液标本,用于建立FISH阈值,作为阳性判断的标准。结果细胞学和FISH的总体灵敏度分别为43.2%、82.4%,特异度分别为:92.3%、88.5%,诊断符合率分别为:56.0%、84.0%,细胞学和FISH在灵敏度、诊断符合率、非浸润性肿瘤和初发肿瘤等方面的差异均有统计学意义。结论在膀胱癌诊断中FISH较常规细胞学具有较高的灵敏度和诊断符合率,更易检出早期肿瘤。 Objective To assess the value of fluorescence in situ hybridization (FISH) in the diagnosis of bladder cancer. Methods Urine samples from 100 patients suspected of having bladder cancer were collected before cystoscopy for immediate urine cytology and FISH analysis. The criteria for FISH abnormality were determined by evaluating the urine specimens from 20 subjects without urogenital neoplasm. Results The overall sensitivity of cytology and FISH was 43.2% and 82.4%, and their specificity was 92.3% and 88.5%, with diagnostic concordance rate of 56.0% and 84.0%, respectively. The differences between FISH and cytology showed statistical significance in the sensitivity, diagnostic concordance rate, non-muscle-invasive cancer and primary cancer. Conclusion The sensitivity and efficiency of FISH in the detection of bladder cancer are superior to those of cytology, especially for prophase cancer.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第7期1597-1599,1603,共4页 Journal of Southern Medical University
基金 卫生部科研基金(WKJ2007-3-001)
关键词 荧光原位杂交 膀胱肿瘤 细胞学 fluorescence in situ hybridization bladder cancer cytology
  • 相关文献

参考文献12

  • 1Messing EM, Young TB, Hunt VB, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations [ J ]. Urology, 1995, 45(3): 387-396.
  • 2Sandberg AA, Berger CS. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer [J]. J Urol, 1994, 151(3): 545-60.
  • 3Sokolova IA, Hailing KC, Jenkins RB, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection ofurothelial carcinoma in urine [J]. J Mol Diagn, 2000, 2(3): 116-23.
  • 4Friedrich MG, Toma MI, Hellstern A, et al. Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer [J]. BJU Int, 2003, 92 (9): 911-4.
  • 5BubendorfL, Grilli B, Sauter G, et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings[J]. Am J Clin Pathol, 2001, 116(1): 79-86.
  • 6Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese [J]. Carcinogenesis, 2004, 25 (3): 343-7.
  • 7Lotan Y, Bensalah K, Ruddell T, et al. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder[J]. J Urol, 2008, 179(6): 2164-9.
  • 8Kwak C, Ku JH, Park JY, ct al. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer[J]. J Urol, 2004, 171(1): 149-52.
  • 9Hailing KC, Kipp BR. Bladder cancer detection using FISH (UroVysion assay)[J]. Adv Anat Pathol, 2008, 15(5): 279-86.
  • 10Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology[J]. J Urol, 2003, 169(6): 2101-5.

同被引文献78

  • 1穆大为,周利群,丁义,何志嵩,王莹,何群,杨新宇.应用荧光原位杂交技术检测膀胱尿路上皮癌的研究[J].中华临床医师杂志(电子版),2010,4(7):976-980. 被引量:5
  • 2Jones JS. DNA-based molecular cytology for bladder cancer sur-veillance. Urology, 2006,67 ( Suppl 1) : 35-47.
  • 3Hailing KC,King W,Sokolova IA,et al. A comparsion of cytol-ogy and fluorescence in situ hybridization for the detection ofurothelial carcinoma. J Urol, 2000,164 : 1768-1775.
  • 4Lotan Y,Bensalah K, Ruddell T,et al. Prospective evaluationof the clinical usefulness of reflex fluorescence in situ hybridiza-tion assay in patients with atypical cytology for the detection ofurothelial carcinoma of the bladder. J Urol, 2008 , 179 : 2164-2169.
  • 5Marin-Aguilera M,Mengual L, Ribal MJ,et al. Utility of a mul-tiprobe fluorescence in situ hybridization assay in the detection ofsuperficial urothelialbladder cancer. Cancer Genet Cytogenet,2007’ 173: 131-135.
  • 6Kwak KW, Kim SH , Lee HM , et al. The utility of fluorescencein situ hybridization for detection of bladder urothelial carcinomain routine clinical practice. J Korean Med Sci, 2009 , 24 : 1139-1144.
  • 7Varella-Garcia M,Akduman B , Sunpaweravong P, et al. Theurovysion fluorescence in situ hybridization assay is an effec-tive tool for monitoring recurrence of bladder cancer. Urol On-col, 2004’ 22: 16-19.
  • 8Kang JU,Koo SH, Jeong TE,et al. Multitarget fluorescence insitu hybridization and melanoma antigen genes analysis in primarybladder carcinoma. Cancer Genet Cytogenet, 2006,164 : 32-38.
  • 9Sarosdy MF, Schellhammer P,Bokinsky G, et al. Clinical eval-uation of a multitarget fluorescent in situ hybridization assay fordetection of bladder cancer. J Urol, 2002,168 : 1950-1954.
  • 10Yoder BJ,Skacel M , Hedgepeth R , et al. Reflex urovysion tes-ting of bladder cancer surveillance patients with equivocal or neg-ative urine cytology. Am J Clin Pathol, 2007 , 127 : 295 -301.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部